Principal Securities »

Dianthus Therapeutics shares owned by Principal Securities

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Principal Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $432 11 39.36
2025-06-30 $205 11 18.64

More positions owned by Principal Securities

Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Principal Exchange Traded Focused Blue Chi (BCHP)
Principal Exchange Traded Prin U S Small (PSC)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Microsoft Corporation (MSFT)
Principal Exchange Traded Intl Equity Etf (PIEQ)
Ishares Tr Core S&p Us Vlu (IUSV)
Spdr Series Trust Portfolio S&p500 (SPLG)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Principal Exchange Traded Prnc Invt Grad (IG)
Ishares Tr Rus 1000 Etf (IWB)

View all positions for Principal Securities

Top funds holding Dianthus Therapeutics

FMR
Fairmount Funds Management
Avidity Partners Management
RA Capital Management
Wellington Management Company
Octagon Capital Advisors
Point72 Asset Management
TCG Crossover Management
Vanguard Group
BlackRock
Bain Capital Life Sciences Investors
Vestal Point Capital
Citadel Advisors
VR Adviser
Alliancebernstein

View all funds holding Dianthus Therapeutics